BOXR1030 T Cells

· Sotio Biotech Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BOXR1030 T Cells, covering 2025-12-05 to 2025-12-05. Get the full timeline:

Most recent: Clinical Trial Update: BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors [Phase 1, Phase 2]